NEW YORK, August 9, 2016 /PRNewswire/ -- Sentiments over the Biotech industry have improved in previous weeks on confidence over drug pipelines and better global conditions. However, stocks are still down 13% this year. Today, Stock-Callers.com reviews four names to see how they have...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]d-rexahn-pharma-589600271.html